Jul 17, 2026

Bitcoin bottom countdown nears 50 days after BTC supply in loss passed 50%

Bitcoin supply in loss hit 50% nearly 50 days ago, mimicking the countdown to BTC price bear-market bottoms.Bitcoin (BTC) has been...

Jul 17, 2026

Microsoft (MSFT) Stock Surges on Strong Azure Demand in Latest CIO Survey

Microsoft (MSFT) stock rose 1.4% to $401 as CIO survey data showed Azure demand at multi-year highs. Morgan Stanley maintains $650...

Jul 17, 2026

Nebius (NBIS) Stock Plunges Nearly 14% Amid Insider Selling and Model Shift Conc...

Nebius (NBIS) stock tumbled 14% Thursday on asset-light model worries, massive insider selling, elevated capex guidance, and Meta...

Jul 17, 2026

Faraday Future (FFAI) Stock Tumbles 8.85% as AI Robotics Partnerships Accelerate

Faraday Future (FFAI) stock dropped 8.85% despite showcasing AI robotics at Silicon Valley events and expanding its Four-Core Full...

Jul 17, 2026

Bitcoin Price Prediction: Larry Fink Turns Bullish on BTC, Blames Leverage Tradi...

Larry Fink is bullish on Bitcoin price after one of the year's sharpest leverage flushes in a bearish prediction environment.The...

Jul 17, 2026

Vertiv (VRT) Stock: The Hidden AI Infrastructure Giant Delivering 82% Returns in...

Vertiv (VRT) stock gains 82% YTD with Baird's Buy rating at $370 target. Q1 sales rose 30%, $15B backlog. Q2 earnings July 29. Ana...

Jul 17, 2026

US indicts crypto investor over alleged $20M fraud scheme

Federal prosecutors allege the South Dakota investor used false promises to raise money, repaid earlier investors with new funds a...

Jul 17, 2026

Bloom Energy (BE) Stock Plunges 14%: Is This Dip a Strategic Entry Point?

Bloom Energy (BE) stock fell 14% Thursday on supply chain worries and short-seller concerns, but analysts maintain positive outloo...

Jul 17, 2026

Coinbase CEO Dismisses Calls for Additional AI Watchdog

TLDR Coinbase CEO Brian Armstrong rejected proposals for a new AI self-regulatory body. Armstrong argued existing fraud, tort, and...

Jul 17, 2026

Merck (MRK) Stock Rallies Following FDA Approval of Breakthrough Cholesterol Med...

Merck (MRK) gains momentum as FDA approves Lipfendra, the first oral PCSK9 inhibitor for cholesterol, priced at $315/month with $5...